• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome

tetano

Editor, Senior Moderator
Curr Opin Chem Biol. 2014 Feb 5;18C:87-94. doi: 10.1016/j.cbpa.2014.01.007. [Epub ahead of print]
The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome.
Palma AS1, Feizi T2, Childs RA3, Chai W3, Liu Y4.
Author information
Abstract

The neoglycolipid (NGL) technology is the basis of a state-of-the-art oligosaccharide microarray system. The NGL-based microarray system in the Glycosciences Laboratory Imperial College London (http://www3.imperial.ac.uk/glycosciences) is one of the two leading platforms for glycan microarrays, being offered for screening analyses to the broad biomedical community. Highlighted in this review are the sensitivity of the analysis system and, coupled with mass spectrometry, the provision for generating 'designer' microarrays from glycomes to identify novel ligands of biological relevance. Among recent applications are assignments of ligands for apicomplexan parasites, pandemic 2009 influenza virus, polyoma and reoviruses, an innate immune receptor against fungal pathogens, Dectin-1, and a novel protein of the endoplasmic reticulum, malectin; also the characterization of an elusive cancer-associated antigen. Some other contemporary advances in glycolipid-containing arrays and microarrays are also discussed.

Copyright ? 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

PMID:
24508828
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24508828
 
Back
Top Bottom